MyCardium AI

It has been one month since the 2024 Merseyside Independent Business Awards, and we’re still thrilled to have taken home Best Creative Business and Digital and Technology Business of the Year! 🏆✨ A huge thank you to our team and everyone who supports us on this journey. These awards are a testament to the dedication, innovation, and creativity we strive for every day. Here’s to even more growth in the months ahead! #MIBAwards2024 #Innovation #Creativity #Teamwork #AI

We’re thrilled to announce that MyCardium will be attending the 2024 AHA Conferences in Chicago from November 16th to 18th! Connect with our Core Lab services to assist with your clinical trial. Email us to schedule a meeting here: [email protected] Click here for more information on our Core Lab services https://lnkd.in/eeNn7cGD #AHA2024 #CardiovascularInnovation #CardiacCare

Join us in welcoming Chloe Bickerstaff to our team as Head of Core Lab Operations! Chloe will be responsible for the day-to-day operations of our Core Lab, overseeing our excellent Core Lab team and its delivery of services to our customers.

Reflecting on our two-year anniversary just a few months ago, we are now celebrating our ISO 13485 accreditation! 🎉 In a short time, what began as a bold vision has evolved to meet the highest industry standards in quality and safety. This achievement underscores our commitment to providing safe, effective, and high-quality AI-driven medical solutions. MyCardium’s growth is a testament to the dedication and hard work of our incredible team — thank you to everyone who has been part of this journey with us. Click here for our newsletter, which outlines what this accreditation means for MyCardium AI: https://lnkd.in/eDAZhASn #ISO13485 #QualityCommitment #MilestoneAchievement #LookingForward

Securing ISO 13485 accreditation is a major milestone for us at MyCardium AI, signifying that our operations and products align with the stringent global standards for medical device quality and safety. This achievement demonstrates our unwavering focus on the following key areas: ✔Safety and Reliability 🔎Regulatory Compliance 💡Innovation with Accountability Watch the video below to hear from Michael Walker, Head of Regulatory, as he discusses the significance of such accreditations and their impact on our flagship solutions—Echo AI and 1CMR 🎥 #1CMR #Revolutionary #AI #Medicaldevices

🚀 Exciting News: MyCardium AI Achieves ISO 13485 Accreditation! 🚀 We are thrilled to announce that MyCardium AI has officially received ISO 13485 accreditation, an internationally recognized standard for quality management systems in medical devices. This achievement underscores our commitment to delivering safe, reliable, and cutting-edge AI solutions for the healthcare industry. With ISO 13485 certification, our AI software products are now further validated for their quality and consistency, ensuring that we continue to meet the highest global standards in cardiovascular imaging. This milestone represents our dedication to empowering clinicians with the tools they need for precise and effective patient care. A heartfelt thank you to the entire MyCardium AI team for their relentless efforts in making this possible. We also extend our gratitude to our partners, and supporters for your ongoing trust and collaboration. Together, we’re shaping the future of healthcare! 🩺💡 #ISO13485 #MedicalDevices #MyCardiumAI #HealthcareInnovation #CardiovascularAI #ThankYou

We are excited to be part of #ESCR2024 for their annual scientific meeting later this week! This event brings together leading experts in the field to share their insights and innovations. Our CEO, Prof. James Moon, will be presenting on left ventricular hypertrophy, discussing how cardiac MRI can help identify the presence and causes of heart thickening, and how to precision treat and monitor such patients. Join us this Thursday in Room 2 for "ESCR meets SCMR: New Imaging Insights into Cardiomyopathies" from 15:15 to 16:45

We are thrilled to announce that we have won not one, but two awards at the prestigious Merseyside Independent Business Awards! We've been named Digital & Technology Business of the Year and Creative Business of the Year. This recognition underscores our commitment to driving innovation through our #EchoAI and #1CMR solutions. The event, held at the stunning Titanic Hotel in #Liverpool, was a night to remember. Huge thanks to our incredible team and partners for making this possible! Here's to continuing our mission of transforming cardiac care. #MIBAwards #DigitalAndTech #CreativeBusiness #EchoAI #1CMR #HealthcareInnovation

🚀 Breaking news! 🚀 Guilford Street Laboratories (GSL) is excited to announce that "PD Predict", our ground breaking blood-based diagnostic test for Parkinson's disease, has been granted Breakthrough Device Designation by the U.S. Food and Drug Administration (FDA). The FDA's Breakthrough Devices Program supports the development of medical devices that offer more effective treatments or diagnostics for life-threatening or irreversibly debilitating conditions. This accelerated pathway is expected to help patients gain access to GSL's innovative diagnostic tool sooner. We are thrilled by this significant mile-stone in our journey - stay tuned for updates as we strive to improve the diagnostic pathway for Parkinson's disease patients worldwide. #GuilfordStreetLabs #GSL #diagnostics #parkinsonsdisease #biomarkers #breakthroughdesignation #FDA

Join us in welcoming Jim Williams to our team as Head of IT! Jim will be enhancing our internal IT offerings and leading developments to improve our customer facing IT to ensure performance, security and compliance across the board.